Compare NHTC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHTC | VRCA |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 32.7M |
| IPO Year | 1995 | 2018 |
| Metric | NHTC | VRCA |
|---|---|---|
| Price | $3.55 | $8.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 37.4K | ★ 195.3K |
| Earning Date | 02-04-2026 | 11-14-2025 |
| Dividend Yield | ★ 22.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,873,000.00 | $30,829,000.00 |
| Revenue This Year | N/A | $373.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 234.73 |
| 52 Week Low | $2.40 | $3.28 |
| 52 Week High | $6.00 | $9.82 |
| Indicator | NHTC | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 53.31 |
| Support Level | $3.12 | $7.79 |
| Resistance Level | $3.85 | $8.27 |
| Average True Range (ATR) | 0.21 | 0.59 |
| MACD | 0.05 | -0.15 |
| Stochastic Oscillator | 72.78 | 26.76 |
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.